Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-023141

bluebird bio, Inc. · BLUE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Daniel Lynch
Director
Period of report
Mar 24, 2017
Accepted (ET)
Mar 28, 2017 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMar 24, 2017M2,000$2.0864A3,400D
Common StockF2Mar 24, 2017S1,700$87.098D1,700D
Common StockF3Mar 24, 2017S300$87.6333D1,400D
Common StockMar 27, 2017M1,000$2.0864A2,400D
Common StockMar 27, 2017S1,000$90.00D1,400D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F4$2.0864Mar 24, 2017M2,000D—Jul 13, 2021Common Stock2,00016,271D
Stock Option (right to buy)F4$2.0864Mar 27, 2017M1,000D—Jul 13, 2021Common Stock1,00015,271D

Explanation of responses